UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIBA gene resulting in platelet-type von Willebrand disease

Blood, 2005-06, Vol.105 (11), p.4330-4336

2005

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic Growth Factors Signal Through the Formation of Reactive Oxygen Species

Blood, 1999-05, Vol.93 (9), p.2928-2935

1999

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic Growth Factors Signal Through the Formation of Reactive Oxygen Species

Blood, 1999-05, Vol.93 (9), p.2928-2935

1999

Link zum Volltext

Verfügbarkeit prüfen

Thrombin Generation by Apoptotic Vascular Smooth Muscle Cells

Blood, 1997-06, Vol.89 (12), p.4378-4384

1997

Link zum Volltext

Verfügbarkeit prüfen

Atherogenic lipoproteins support assembly of the prothrombinase complex and thrombin generation : Modulation by oxidation and vitamin E

Blood, 1998-01, Vol.91 (2), p.508-515

1998

Link zum Volltext

Verfügbarkeit prüfen

Atherogenic Lipoproteins Support Assembly of the Prothrombinase Complex and Thrombin Generation: Modulation by Oxidation and Vitamin E

Blood, 1998-01, Vol.91 (2), p.508-515

1998

Link zum Volltext

Verfügbarkeit prüfen

Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins

Blood, 1999-06, Vol.93 (11), p.3792-3797

1999

Link zum Volltext

Verfügbarkeit prüfen

Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins

Blood, 1999-06, Vol.93 (11), p.3792-3797

1999

Link zum Volltext

Verfügbarkeit prüfen

Identification and Functional Characterization of a Novel 27bp Deletion in the Macroglycopeptide-Coding Region of the GPIbα Gene Resulting in Platelet-Type Von Willebrand Disease

Blood, 2004-11, Vol.104 (11), p.1023-1023

2004

Link zum Volltext

Verfügbarkeit prüfen

Side Effects and Supportive Care in Relapsed or Refractory Classical Hodgkin Lymphoma Patients Treated in Later Lines of Therapy: A Pilot Analysis Conducted in 4 Countries

Blood, 2017-12, Vol.130, p.5653-5653

2017

Link zum Volltext

Verfügbarkeit prüfen

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

Blood, 2013-05, Vol.121 (22), p.4439-4442

2013

Link zum Volltext

Verfügbarkeit prüfen

Spirit 2: Final 5 Year Analysis of the UK National Cancer Research Institute Randomized Study Comparing Imatinib with Dasatinib in Patients with Newly Diagnosed Chronic Phase CML

Blood, 2018-11, Vol.132 (Supplement 1), p.457-457

2018

Link zum Volltext

Verfügbarkeit prüfen

Increased PKR Expression Promotes MDS Evolution to Acute Leukemia in the NHD13 Mouse Model

Blood, 2014-12, Vol.124 (21), p.1900-1900

2014

Link zum Volltext

Verfügbarkeit prüfen

Chronic Myeloid Leukaemia Patients with Stable Molecular Responses (at least MR3) May Safely Decrease the Dose of Their Tyrosine Kinase Inhibitor: Data from the British Destiny Study

Blood, 2016-12, Vol.128 (22), p.938-938

2016

Link zum Volltext

Verfügbarkeit prüfen

Extracorporeal Photopheresis As Second Line Therapy for Steroid Refractory Acute Gvhd: Retrospective Study of Long-Term Outcomes

Blood, 2015-12, Vol.126 (23), p.1944-1944

2015

Link zum Volltext

Verfügbarkeit prüfen

Spirit 2: An NCRI Randomised Study Comparing Dasatinib with Imatinib in Patients with Newly Diagnosed CML

Blood, 2014-12, Vol.124 (21), p.517-517

2014

Link zum Volltext

Verfügbarkeit prüfen

Response Post-First Autologous Stem Cell Transplantation for Multiple Myeloma May Identify Patients Who Will Benefit From Tandem Transplants: A Single Center Prospective Phase II Study- an Update

Blood, 2012-11, Vol.120 (21), p.2023-2023

2012

Link zum Volltext

Verfügbarkeit prüfen

Pre-Transplant Rituximab Is Associated with a Greatly Reduced Risk of Epstein-Barr Virus Reactivation Following Allogeneic Stem Cell Transplantation

Blood, 2012-11, Vol.120 (21), p.460-460

2012

Link zum Volltext

Verfügbarkeit prüfen

Immunoglobulin and T Cell Receptor Gene Rearrangements in Human Lymphoma and Leukemia

Blood, 1987-01, Vol.69 (1), p.79-86

1987

Link zum Volltext

Verfügbarkeit prüfen

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAnz Journal Of Surgery

Zeitschrift / SerieBlood

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Japanisch
(5)

Erscheinungsjahr

n.n

Kollektion

Menü

Weitere Dienste

Einstellungen

Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIBA gene resulting in platelet-type von Willebrand disease

Hematopoietic Growth Factors Signal Through the Formation of Reactive Oxygen Species

Hematopoietic Growth Factors Signal Through the Formation of Reactive Oxygen Species

Thrombin Generation by Apoptotic Vascular Smooth Muscle Cells

Atherogenic lipoproteins support assembly of the prothrombinase complex and thrombin generation : Modulation by oxidation and vitamin E

Atherogenic Lipoproteins Support Assembly of the Prothrombinase Complex and Thrombin Generation: Modulation by Oxidation and Vitamin E

Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins

Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins

Identification and Functional Characterization of a Novel 27bp Deletion in the Macroglycopeptide-Coding Region of the GPIbα Gene Resulting in Platelet-Type Von Willebrand Disease

Side Effects and Supportive Care in Relapsed or Refractory Classical Hodgkin Lymphoma Patients Treated in Later Lines of Therapy: A Pilot Analysis Conducted in 4 Countries

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

Clinical Activity of Melflufen in Patients with Triple-Class Refractory Multiple Myeloma and Poor-Risk Features in an Updated Analysis of HORIZON (OP-106), a Phase 2 Study in Patients with Relapsed/Refractory Multiple Myeloma Refractory to Pomalidomide and/or Daratumumab

Spirit 2: Final 5 Year Analysis of the UK National Cancer Research Institute Randomized Study Comparing Imatinib with Dasatinib in Patients with Newly Diagnosed Chronic Phase CML

Increased PKR Expression Promotes MDS Evolution to Acute Leukemia in the NHD13 Mouse Model

Chronic Myeloid Leukaemia Patients with Stable Molecular Responses (at least MR3) May Safely Decrease the Dose of Their Tyrosine Kinase Inhibitor: Data from the British Destiny Study

Extracorporeal Photopheresis As Second Line Therapy for Steroid Refractory Acute Gvhd: Retrospective Study of Long-Term Outcomes

Melflufen Therapy for Relapsed Refractory Multiple Myeloma (RRMM) Patients Refractory to Daratumumab and/or Pomalidomide: A Report on Early Efficacy

Spirit 2: An NCRI Randomised Study Comparing Dasatinib with Imatinib in Patients with Newly Diagnosed CML

Assessment of Quality of Life in the NCRI Spirit 2 Study Comparing Imatinib with Dasatinib in Patients with Newly-Diagnosed Chronic Phase Chronic Myeloid Leukaemia

Response Post-First Autologous Stem Cell Transplantation for Multiple Myeloma May Identify Patients Who Will Benefit From Tandem Transplants: A Single Center Prospective Phase II Study- an Update

Pre-Transplant Rituximab Is Associated with a Greatly Reduced Risk of Epstein-Barr Virus Reactivation Following Allogeneic Stem Cell Transplantation

Immunoglobulin and T Cell Receptor Gene Rearrangements in Human Lymphoma and Leukemia

Aktive Filter

Suchergebnisse filtern